- Home
- RNA vs BCPC Comparison
RNA vs BCPC Comparison
Compare RNA & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | BCPC |
|---|---|---|
| Founded | 2012 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | BCPC |
|---|---|---|
| Price | $72.19 | $157.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 2 |
| Target Price | $69.26 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.3M | 225.4K |
| Earning Date | 11-10-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | N/A | ★ 22.48 |
| EPS | N/A | ★ 4.57 |
| Revenue | $20,868,000.00 | ★ $1,013,548,000.00 |
| Revenue This Year | $64.11 | $10.52 |
| Revenue Next Year | $37.25 | $5.69 |
| P/E Ratio | ★ N/A | $34.36 |
| Revenue Growth | ★ 106.27 | 7.55 |
| 52 Week Low | $21.51 | $139.17 |
| 52 Week High | $72.61 | $177.40 |
Technical Indicators
Market Signals| Indicator | RNA | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 73.51 | 54.32 |
| Support Level | $71.99 | $155.46 |
| Resistance Level | $72.61 | $158.61 |
| Average True Range (ATR) | 0.28 | 3.96 |
| MACD | -0.37 | 0.25 |
| Stochastic Oscillator | 69.93 | 70.04 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.